Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ochsendorf

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Gastroenterology|June 11, 1999
Photoallergic skin reaction to ribavirinD Stryjek-Kaminska, F Ochsendorf, C Röder, et al.
Medical Hypotheses|September 1, 1991
Oxidative imbalance in HIV infected patientsJ Fuchs, F Ochsendorf, H Schöfer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 10, 2002
[Main symptom: unfulfilled wish to have children]F Ochsendorf, F M Köhn, G Haidl, et al.
The British Journal of Dermatology|May 16, 2000
Cream PUVA therapy for scleredema adultorumM Grundmann-Kollmann, F Ochsendorf, T M Zollner, et al.
Andrologia|February 18, 2014
Macrophage metalloelastase-12 is detectable in human seminal plasma and represents a predictor for inflammatory processes in the male genital tractA Urbschat, P Paulus, I Wiegratz, et al.
Archives of Dermatology|July 17, 2001
Mycophenolate mofetil is effective in the treatment of atopic dermatitisM Grundmann-Kollmann, M Podda, F Ochsendorf, et al.
The British Journal of Dermatology|March 26, 2003
The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticariaW-H Boehncke, R J Ludwig, T M Zollner, et al.
The British Journal of Dermatology|November 25, 2010
Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?M Schuster, C C Zouboulis, F Ochsendorf, et al.
Molecular Medicine (Cambridge, Mass.)|June 27, 1998
Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignanciesJ Fuchs, N Oelke, M Imhof, et al.
Journal of the American Academy of Dermatology|September 27, 2000
PUVA-cream photochemotherapy for the treatment of localized sclerodermaM Grundmann-Kollmann, F Ochsendorf, T M Zollner, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Gastroenterology|June 11, 1999
Photoallergic skin reaction to ribavirinD Stryjek-Kaminska, F Ochsendorf, C Röder, et al.
Medical Hypotheses|September 1, 1991
Oxidative imbalance in HIV infected patientsJ Fuchs, F Ochsendorf, H Schöfer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 10, 2002
[Main symptom: unfulfilled wish to have children]F Ochsendorf, F M Köhn, G Haidl, et al.
The British Journal of Dermatology|May 16, 2000
Cream PUVA therapy for scleredema adultorumM Grundmann-Kollmann, F Ochsendorf, T M Zollner, et al.
Andrologia|February 18, 2014
Macrophage metalloelastase-12 is detectable in human seminal plasma and represents a predictor for inflammatory processes in the male genital tractA Urbschat, P Paulus, I Wiegratz, et al.
Archives of Dermatology|July 17, 2001
Mycophenolate mofetil is effective in the treatment of atopic dermatitisM Grundmann-Kollmann, M Podda, F Ochsendorf, et al.
The British Journal of Dermatology|March 26, 2003
The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticariaW-H Boehncke, R J Ludwig, T M Zollner, et al.
The British Journal of Dermatology|November 25, 2010
Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?M Schuster, C C Zouboulis, F Ochsendorf, et al.
Molecular Medicine (Cambridge, Mass.)|June 27, 1998
Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignanciesJ Fuchs, N Oelke, M Imhof, et al.
Journal of the American Academy of Dermatology|September 27, 2000
PUVA-cream photochemotherapy for the treatment of localized sclerodermaM Grundmann-Kollmann, F Ochsendorf, T M Zollner, et al.
Pageof 4